Norepinephrine transporter and Serotonin transporter (NET and SERT)

The process referred to as "noradrenaline and serotonin reuptake" is mediated by two distinct but related membrane proteins—the norepinephrine transporter (NET) and the serotonin transporter (SERT). Both belong to the solute carrier family six group of sodium-dependent neurotransmitter symporters. These proteins reside on presynaptic neuronal membranes where they rapidly clear their respective monoamine neurotransmitters—norepinephrine/ noradrenaline via NET; serotonin via SERT—from the synaptic cleft back into nerve terminals after release.\n\nThis clearance is essential for terminating signal transmission at monoaminergic synapses as well as recycling neurotransmitters for future use. Dysregulation or inhibition of either protein alters brain chemistry underlying mood regulation, attention control, pain perception and other neurophysiological processes.\n\nBoth transporters are major therapeutic targets in psychiatry—most notably for antidepressants such as selective NRIs/SNRIs which block their activity to increase extracellular levels of monoamines. Drugs acting on these targets have proven efficacy against depression/anxiety disorders but can cause side effects due to altered sympathetic tone or serotonergic signaling.[1][3][5][7]\n\nIn summary: "Noradrenaline and serotonin reuptake" describes a physiological process carried out by two key molecular targets—the norepinephrine/noradrenaline transporter (NET/NAT/SLC6A2) and the serotonin transporter (SERT/SLC6A4)—which are integral membrane proteins classified as sodium-dependent neurotransmitter symporters involved in regulating central nervous system function through control over monoamine signaling.[1][2][3]

Other names

Noradrenaline transporter (NAT)Norepinephrine reuptake transporterSerotonin reuptake transporterSLC6A2 (for NET)SLC6A4 (for SERT)

Drugs targeting these transporters act primarily by inhibiting the reuptake function—blocking NET and/or SERT increases extracellular concentrations of norepinephrine and/or serotonin in the synapse. This enhances neurotransmission at adrenergic or serotonergic receptors downstream. Some drugs selectively inhibit one transporter; others inhibit both to varying degrees